These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28789399)
1. Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma. Zhang J; Wei B; Hu H; Liu F; Tu Y; Zhao M; Wu D Oncol Lett; 2017 Aug; 14(2):1711-1718. PubMed ID: 28789399 [TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma. Xu M; Xu T Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between Chemotactic Factor CCL5 and Diabet-associated Diffuse Large B Cell Lymphoma]. Zhang JC; Liu FR; Hu HX; He F; Tu Y; Wei B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1325-30. PubMed ID: 26524031 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients. Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma. Yang JM; Jang JY; Jeon YK; Paik JH J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998 [TBL] [Abstract][Full Text] [Related]
7. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression. Yang W; Li Y; Li P; Wang L Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720 [TBL] [Abstract][Full Text] [Related]
8. [Expression and Clinical Significance of MicroRNA-195 in Patients with Diffuse Large B Cell Lymphoma]. Liu RD; Zhuang W; Qi JD; Li CC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):160-164. PubMed ID: 32027270 [TBL] [Abstract][Full Text] [Related]
9. miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma. Wang X; Kan Y; Chen L; Ge P; Ding T; Zhai Q; Yu Y; Wang X; Zhao Z; Yang H; Liu X; Li L; Qiu L; Qian Z; Zhang H; Wang Y; Zhao H Oncol Lett; 2020 May; 19(5):3487-3494. PubMed ID: 32269622 [TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5. Zhang J; Luo J; Liu F; Wu D; Zhong Q; Zeng L; Wu Z; Zhao T; Wu L; Hao H Mol Med Rep; 2014 Sep; 10(3):1231-6. PubMed ID: 24938715 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2. Liu K; Du J; Ruan L Exp Ther Med; 2017 Nov; 14(5):4489-4496. PubMed ID: 29067124 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma. Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551 [TBL] [Abstract][Full Text] [Related]
13. [Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance]. Song GQ; Gu L; He BS; Pan YQ; Wang SK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1603-9. PubMed ID: 25543482 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the MIR155 host gene in physiological and pathological processes. Elton TS; Selemon H; Elton SM; Parinandi NL Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696 [TBL] [Abstract][Full Text] [Related]
15. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment]. Cao QW; Li HY; Yao XX; Wang JF Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792 [TBL] [Abstract][Full Text] [Related]
16. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma]. Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247 [No Abstract] [Full Text] [Related]
17. Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma. Serag El-Dien MM; Abdou AG; Asaad NY; Abd El-Wahed MM; Kora MAEM Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):534-542. PubMed ID: 26862953 [TBL] [Abstract][Full Text] [Related]
18. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma. Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma. Chen L; Kan Y; Wang X; Ge P; Ding T; Zhai Q; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Liu X; Li L; Qiu L; Zhang H; Qian Z; Zhao H Oncol Lett; 2020 Oct; 20(4):93. PubMed ID: 32831912 [TBL] [Abstract][Full Text] [Related]
20. mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment. Zhai L; Zhao Y; Liu Z; Wu J; Lin L Exp Ther Med; 2020 Sep; 20(3):2157-2165. PubMed ID: 32765691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]